Stock Comparison

ARWR vs REGN

Arrowhead Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ARWR

Arrowhead Pharmaceuticals Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.00B

$80.55B

P/E (TTM)

—

19.4

Forward P/E

107.7

17.1

Price/Sales

17.9

5.2

Price/Book

25.8

2.5

EV/EBITDA

27.0

13.1

Dividend Yield

—

0.45%

Profitability

Net Margin

-47.79%

29.65%

Operating Margin

-33.82%

24.32%

Return on Equity

-55.20%

14.00%

Return on Assets

-8.10%

6.53%

Growth (YoY)

Revenue Growth

171.00%

16.70%

Earnings Growth

9.80%

-4.50%

Price & Risk

Beta

1.3

0.2

52-Week High

$89.59

$810.12

52-Week Low

$18.78

$553.38

Analyst Target

$110.18

$833.54

Compare ARWR and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.